Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulation

Physiological Reports

Volumn 4, Issue 12, 2016, Pages

  Tanimura, Yuko ^a,b   Aoi, Wataru ^c   Takanami, Yoshikazu ^d   Kawai, Yukari ^e   Mizushima, Katsura ^a   Naito, Yuji ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b AICHI TOHO UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

^d OTSUMA WOMEN'S UNIVERSITY   (Japan)

^e Louis Pasteur Center for Medical Research   (Japan)

Author keywords

Fibroblast growth factor 21; glucose uptake; muscle contraction; phosphorylation of Akt

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21;

ADULT; ANIMAL; ANIMAL EXPERIMENT; BLOOD; EXERCISE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; MALE; METABOLISM; MOUSE; PHYSIOLOGY; SKELETAL MUSCLE;

ADULT; ANIMALS; FIBROBLAST GROWTH FACTORS; HUMANS; LIVER; MALE; MICE; MICE, INBRED ICR; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL CONDITIONING, HUMAN;

EID: 84977504316     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12828     Document Type: Article

References (32)

1. Badman, M. K., P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier. 2007. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5:426–437.
2. Besse-Patin, A., E. Montastier, C. Vinel, I. Castan-Laurell, K. Louche, C. Dray, et al. 2014. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int. J. Obes. (Lond) 38:707–713.
3. Chambers, M. A., J. S. Moylan, J. D. Smith, L. J. Goodyear, and M. B. Reid. 2009. Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase. J. Physiol. 587:3363–3373.
4. Cuevas-Ramos, D., P. Almeda-Valdés, C. E. Meza-Arana, G. Brito-Córdova, F. J. Gómez-Pérez, R. Mehta, et al. 2012. Exercise increases serum fibroblast growth factor 21 (FGF21) levels. PLoS ONE 7:e38022.
5. Deshmukh, A., V. G. Coffey, Z. Zhong, A. V. Chibalin, J. A. Hawley, and J. R. Zierath. 2006. Exercise-induced phosphorylation of the novel Akt substrates AS160 and filamin A in human skeletal muscle. Diabetes 55:1776–1782.
6. Dill, D. B., and D. L. Costill. 1974. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J. Appl. Physiol. 37:247–248.
7. Dutchak, P. A., T. Katafuchi, A. L. Bookout, J. H. Choi, R. T. Yu, D. J. Mangelsdorf, et al. 2012. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 148:556–567.
8. Fletcher, J. A., G. M. Meers, M. H. Laughlin, J. A. Ibdah, J. P. Thyfault, and R. S. Rector. 2012. Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction. Appl. Physiol. Nutr. Metab. 37:1054–1062.
9. Guridi, M., L. A. Tintignac, S. Lin, B. Kupr, P. Castets, and M. A. Rüegg. 2015. Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21. Sci. Signal. 8:ra113. doi: 10.1126/scisignal.aab3715.
10. Hansen, J. S., J. O. Clemmesen, N. H. Secher, M. Hoene, A. Drescher, C. Weigert, et al. 2015. Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4:551–560.
11. Hojman, P., M. Pedersen, A. R. Nielsen, R. Krogh-madsen, C. Yfanti, T. Åkerstrom, et al. 2009. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58:2797–2801.
12. Inagaki, T., P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, et al. 2007. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5:415–425.
13. Ito, Y., K. Obara, R. Ikeda, M. Ishii, Y. Tanabe, T. Ishikawa, et al. 2006. Passive stretching produces Akt- and MAPK-dependent augmentations of GLUT4 translocation and glucose uptake in skeletal muscles of mice. Eur. J. Physiol. 451:803–813.
14. Izumiya, Y., H. A. Bina, N. Ouchi, Y. Akasaki, A. Kharitonenkov, and K. Walsh. 2008. FGF21 is an Akt-regulated myokine. FEBS Lett. 582:3805–3810.
15. Ji, K., J. Zheng, J. Lv, J. Xu, X. Ji, Y.-B. Luo, et al. 2015. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR–YY1–PGC1α pathway. Free Radic. Biol. Med. 84:161–170.
16. Keipert, S., M. Ost, K. Johann, F. Imber, M. Jastroch, E. M. van Schothorst, et al. 2014. Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am. J. Physiol. Endocrinol. Metab. 306:82.
17. Kharitonenkov, A., and A. B. Shanafelt. 2008. Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases. BioDrugs 22:37–44.
18. Kharitonenkov, A., T. L. Shiyanova, A. Koester, A. M. Ford, R. Micanovic, E. J. Galbreath, et al. 2005. FGF-21 as a novel metabolic regulator. J. Clin. Investig. 115:1627–1635.
19. Kim, K., S. Kim, Y. Min, H. Yang, J. Lee, and M. Lee. 2013. Acute exercise induces FGF21 expression in mice and in healthy humans. PLoS ONE 7:e63517.
20. Lee, M. S., S.-E. Choi, E. S. Ha, S.-Y. An, T. H. Kim, S. J. Han, et al. 2012. Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB. Metabolism 61:1142–1451.
21. Li, H., Q. Fang, F. Gao, J. Fan, J. Zhou, X. Wang, et al. 2010. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J. Hepatol. 53:934–940.
22. Lindegaard, B., T. Hvid, T. Grøndahl, C. Frosig, J. Gerstoft, P. Hojman, et al. 2013. Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV. PLoS ONE 8:e55632.
23. Mai, K., J. Andres, K. Biedasek, J. Weicht, T. Bobbert, M. Sabath, et al. 2009. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21. Diabetes 58:1532–1538.
24. Mashili, F. L., R. L. Austin, A. S. Deshmukh, T. Fritz, K. Caidahl, K. Bergdahl, et al. 2011. Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 27:286–297.
25. Murata, Y., M. Konishi, and N. Itoh. 2011. FGF21 as an endocrine regulator in lipid metabolism: from molecular evolution to physiology and pathophysiology. J. Nutr. Metab. 2011:981315.
26. Potthoff, M. J., T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, et al. 2009. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl Acad. Sci. USA 106:10853–10858.
27. Rogers, N. H., C. A. Witczak, M. F. Hirshman, L. J. Goodyear, and A. S. Greenberg. 2009. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem. Biophys. Res. Commun. 382:646–650.
28. Sakamoto, K., W. G. Aschenbach, M. F. Hirshman, and L. J. Goodyear. 2003. Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am. J. Physiol. Endocrinol. Metab. 285:E1081–E1088.
29. Sakamoto, K., D. E. W. Arnolds, I. Ekberg, A. Thorell, and L. J. Goodyear. 2004. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem. Biophys. Res. Commun. 319:419–425.
30. Slusher, A. L., M. Whitehurst, R. F. Zoeller, J. T. Mock, M. Maharaj, and C. J. Huang. 2015. Attenuated fibroblast growth factor 21 response to acute aerobic exercise in obese individuals. Nutr. Metab. Cardiovasc. Dis. 25:839–845.
31. Tacer, K. F., A. L. Bookout, X. Ding, H. Kurosu, G. B. John, L. Wang, et al. 2010. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 24:2050–2064.
32. Zhan, M., B. Jin, S. Chen, J. Reecy, and Y. Li. 2007. TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J. Cell Sci. 120:692–701.